Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Hypersensitivity Reaction

  Free Subscription


08.06.2026

1 Acta Derm Venereol
2 Allergy
6 Ann Allergy Asthma Immunol
1 BMC Pediatr
1 BMJ
1 Contact Dermatitis
4 Int Arch Allergy Immunol
3 J Am Acad Dermatol
1 J Dermatol
2 J Invest Dermatol
1 Pediatr Dermatol
1 Pediatrics
1 PLoS Genet
1 PLoS Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Derm Venereol

  1. METSINI A, Ryen L, Montgomery S, Molarius A, et al
    Relationship between Dermatology Life Quality Index Scores and EQ-5D-5L Utility Values in Adults with Atopic Dermatitis: Development of a Swedish Mapping Model.
    Acta Derm Venereol. 2026;106:0277.
    PubMed         Abstract available


    Allergy

  2. NGUYEN TH, Akdis C, Baccarelli A, Banerjee S, et al
    Leveraging Artificial Intelligence in Allergy, Asthma, and Immunology With Environmental Exposures.
    Allergy. 2026 Jun 3. doi: 10.1111/all.70401.
    PubMed         Abstract available

  3. TSUANG AJ, Chung SA, Lin AA, Baloh CH, et al
    Elevated Neonatal Electrical Impedance Spectroscopy Measurements Are Associated With Atopic Dermatitis in High-Risk Infants.
    Allergy. 2026 Jun 2. doi: 10.1111/all.70402.
    PubMed        


    Ann Allergy Asthma Immunol

  4. FINEMAN SM, Hernandez-Trujillo V, Joshi SR, Chow T, et al
    From the pages of AllergyWatch.
    Ann Allergy Asthma Immunol. 2026;136:729-730.
    PubMed        

  5. NOWAK-WEGRZYN A, Levi-Schaffer F
    Meaningful outcomes in food allergy immunotherapy: Measuring what counts.
    Ann Allergy Asthma Immunol. 2026;136:619-620.
    PubMed        

  6. DE BENEDETTO A, Boguniewicz M, Fonacier L, Silverberg J, et al
    Atopic dermatitis Yardstick: a new era of topical and systemic treatments.
    Ann Allergy Asthma Immunol. 2026 Jun 1:S1081-1206(26)00232.
    PubMed         Abstract available

  7. JUNG M, Kyung Y, Kim M, Kim S, et al
    Neonatal urinary phthalate metabolite concentrations are associated with the development of atopic dermatitis.
    Ann Allergy Asthma Immunol. 2026 May 29:S1081-1206(26)00236.
    PubMed         Abstract available

  8. GREIMANN E, Lin CH, Freigeh G, Nelson B, et al
    Treatment for Mild Asthma: What Matters to Providers.
    Ann Allergy Asthma Immunol. 2026 Mar 10:S1081-1206(26)00096.
    PubMed         Abstract available

  9. BUCKEY TM, Frangiosa J, Diem L, Hanna E, et al
    Eosinophilic esophagitis incidence during single and multiple food oral immunotherapy.
    Ann Allergy Asthma Immunol. 2026;136:693-698.
    PubMed         Abstract available


    BMC Pediatr

  10. HUANG S, Zhang Z, Zhang H, Qiu K, et al
    Early life factors and genetic interactions in allergic rhinitis: a genome-wide study.
    BMC Pediatr. 2026 May 30. doi: 10.1186/s12887-026-07052.
    PubMed         Abstract available


    BMJ

  11. NADARAJAH S
    Peanut allergy in adults: how is treatment changing?
    BMJ. 2026;393:s748.
    PubMed        


    Contact Dermatitis

  12. NG KL, Tam MM, Nixon R
    Dupilumab Facial Redness Due to Allergic Contact Dermatitis and Malassezia Hypersensitivity: A Case Report.
    Contact Dermatitis. 2026 Jun 4. doi: 10.1111/cod.70196.
    PubMed        


    Int Arch Allergy Immunol

  13. ALRAFIAAH AS, Khalaf R, Sillcox C, Noorsaeed SM, et al
    Concomitant Chronic Urticaria in Children: A Distinct Severe Phenotype.
    Int Arch Allergy Immunol. 2026;187:599-604.
    PubMed         Abstract available

  14. NACARKUCUK E, Eker I, Gursel O, Bagci S, et al
    Decreased mean platelet volume is associated with loss of asthma control and exacerbation in children with asthma.
    Int Arch Allergy Immunol. 2025 Aug 26:1-21. doi: 10.1159/000547893.
    PubMed         Abstract available

  15. YEGIN KATRAN Z, Bulut I, Salman A
    Low Total IgE Predicts Non-Response to Omalizumab in Chronic Spontaneous Urticaria: A 10-Year Real-Life Study.
    Int Arch Allergy Immunol. 2026;187:605-615.
    PubMed         Abstract available

  16. BURHAN M, Ashraf S, Ali A, Shahid I, et al
    Safety and Efficacy of Remibrutinib for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis.
    Int Arch Allergy Immunol. 2026;187:635-646.
    PubMed         Abstract available


    J Am Acad Dermatol

  17. LULLO JJ
    JAAD Game Changers: "Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)".
    J Am Acad Dermatol. 2026 Jun 3:S0190-9622(26)02816.
    PubMed        

  18. LAKE E
    JAAD Game Changer of the Year: "Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic Dermatitis".
    J Am Acad Dermatol. 2026 Jun 2:S0190-9622(26)02802.
    PubMed        

  19. EZZAT RZ, Paz M, Kreytak C, Senna MM, et al
    Major adverse cardiovascular events and venous thromboembolism in older adults aged 50 or older with atopic dermatitis treated with oral Janus kinase inhibitors: a multicenter cohort study using TriNetX.
    J Am Acad Dermatol. 2026 Jun 2:S0190-9622(26)02800.
    PubMed        


    J Dermatol

  20. TSUNEMI Y, Igarashi A, Ishido T, Saeki H, et al
    Real-World Maintenance of Remission in Atopic Dermatitis Patients With Upadacitinib: A Multicenter Retrospective Study in Japan (ROADMAP Study).
    J Dermatol. 2026 Jun 4. doi: 10.1111/1346-8138.70299.
    PubMed         Abstract available


    J Invest Dermatol

  21. PETERS RHW, Smits JPH, van den Bogaard EH, Kelemen E, et al
    Advantages and limitations of in vitro models for atopic dermatitis: A consensus expert opinion.
    J Invest Dermatol. 2026 Jun 5:S0022-202X(26)01200.
    PubMed         Abstract available

  22. YANG K, Mircescu A, Okusanya D, Mohsen S, et al
    Understanding the Atopic Dermatitis-Psoriasis Phenotypic Switch Through a Pharmacovigilance-Based Approach.
    J Invest Dermatol. 2026 Jun 1:S0022-202X(26)01267.
    PubMed        


    Pediatr Dermatol

  23. BUETHE MG, Sy T, Eichenfield LF
    Safety of Dupilumab and Risk of Cutaneous T-Cell Lymphoma in Pediatric Patients With Atopic Dermatitis: A Data-Driven Guide to Counseling Patients and Families.
    Pediatr Dermatol. 2026 May 31. doi: 10.1111/pde.70285.
    PubMed         Abstract available


    Pediatrics

  24. YOUNG EE, Bullard-Elias D, Faul S, Luong J, et al
    Improving the Delivery of Quality Evidence-Based Inpatient Asthma Care.
    Pediatrics. 2026 May 8:e2025073834. doi: 10.1542/peds.2025-073834.
    PubMed         Abstract available


    PLoS Genet

  25. ZHANG H, He K, Tsoi LC, Zhou X, et al
    mFABIO: An integrative multi-tissue TWAS fine-mapping approach to prioritize potentially causal genes and tissues underlying binary traits.
    PLoS Genet. 2026;22:e1012157.
    PubMed         Abstract available


    PLoS Med

  26. SHAKHSHIR LA, Karain A, Pell JP, Hastie CE, et al
    Prenatal exposure to asthma medications and risk of neurodevelopmental disorders and educational difficulties: A systematic review and meta-analysis.
    PLoS Med. 2026;23:e1005100.
    PubMed         Abstract available


    PLoS One

  27. CHEN X, Zhao L, Luo W
    Study on the pathogenesis of PLXNB1 gene in olfactory dysfunction of allergic rhinitis.
    PLoS One. 2026;21:e0350102.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum